Article ID Journal Published Year Pages File Type
10064714 European Journal of Obstetrics & Gynecology and Reproductive Biology 2005 5 Pages PDF
Abstract
This study did not show any advantage in efficacy or compliance with oxybutynin when two different regimens of low starting were used. Two-thirds of patients discontinued the therapy within 4-6 months. Therefore, patients on anticholinergics should be reassessed after 6 months in clinical practice.
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Authors
, , , , , ,